Our Insights Oncology Anthony Iannacci 4/7/26 Oncology Anthony Iannacci 4/7/26 Lifyorli Approved in Platinum-Resistant Ovarian Cancer Thanks to a 35% Reduction in Mortality Read More Oncology Anthony Iannacci 2/13/26 Oncology Anthony Iannacci 2/13/26 Keytruda Grabs its 42nd Approval in PD-L1+ PROC Read More Want to get in touch? Click here
Oncology Anthony Iannacci 4/7/26 Oncology Anthony Iannacci 4/7/26 Lifyorli Approved in Platinum-Resistant Ovarian Cancer Thanks to a 35% Reduction in Mortality Read More
Oncology Anthony Iannacci 2/13/26 Oncology Anthony Iannacci 2/13/26 Keytruda Grabs its 42nd Approval in PD-L1+ PROC Read More
